SCHEMBL2867293

SCHEMBL2867293

O=Cc1ccc2c(c1)c(-c1cccc(F)c1)nn2C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 4/20 0.43
MAP2K4 P45985 2/20 0.37
PTGER4 P35408 1/20 0.36
DYRK1A Q13627 1/20 0.36
DYRK2 Q92630 1/20 0.36
DYRK1B Q9Y463 1/20 0.36
ICMT O60725 1/20 0.35
ELANE P08246 1/20 0.35
TRIM24 O15164 1/20 0.35
TRIM33 Q9UPN9 1/20 0.35
KDM4E B2RXH2 2/20 0.34
KMO O15229 2/20 0.34
ADORA2A P29274 1/20 0.34
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.34
KMT2A Q03164 1/20 0.34
CSNK2A2 P19784 1/20 0.34
CSNK2B P67870 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2871097 0.84 MAP2K4 (0.56) PTGER1MAP2K4PTGER4DYRK1ADYRK2
SCHEMBL4327851 0.83 PTGER1 (0.45) PTGER1MAP2K4ICMTELANEKDM4E
SCHEMBL6757088 0.82 PTGER1 (0.57) PTGER1ELANEKDM4EADORA2AALDH1A1
SCHEMBL2863245 0.81 PTGER1 (0.43) PTGER1MAP2K4ICMTELANEKDM4E
SCHEMBL2864259 0.80 PTGER1 (0.43) PTGER1MAP2K4ICMTKDM4EALDH1A1
SCHEMBL2871350 0.80 PTGER1 (0.43) PTGER1MAP2K4ICMTKDM4ETBXA2R
SCHEMBL2859046 0.80 TAAR1 (0.46) PTGER1MAP2K4ICMTKDM4EADORA2A
SCHEMBL2860687 0.79 L3MBTL1 (0.54) PTGER1ELANEMEN1KMT2A
SCHEMBL2860693 0.79 L3MBTL1 (0.54) PTGER1ELANEMEN1KMT2A
SCHEMBL2868311 0.78 PTGER1 (0.44) PTGER1ELANEKDM4ETBXA2RPTGDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 PTGER1 3143/4885MAP2K4 61/4885PTGER4 3835/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 PTGER1 4240/4885MAP2K4 53/4885PTGER4 4387/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 PTGER1 3143/4885MAP2K4 61/4885PTGER4 3835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.